Incyte

United Therapeutics

Gilead Sciences

Natera

Alnylam Pharmaceuticals

Neurocrine Biosciences

Vertex Pharmaceuticals

Amgen

Insmed

Sarepta Therapeutics

SPDR S&P Biotech ETF

XBI tracks an equal-weighted index of US biotechnology stocks.

The outlook for the pharmaceutical and biotech industry is good thanks to resilience versus crises and large macro tailwinds.

Is XBI ETF A Buy Or Sell In 2022 For ETF Investors?

Wall Street seems to have a grudge against the entire sector at the moment.

This Trend Is the Biggest Risk to Biotech Investors Right Now

iShares Nasdaq Biotechnology ETF

VanEck Vectors Biotech ETF

The macroeconomic backdrop of Fed interest rate hikes is rapidly deflating overvalued technology companies and "crypto-collectibles." We expect the technology sector to underperform value and biotech.

XBI And IBB: Sell Technology And Buy Biotech, The Only Undervalued Non-Cyclical Growth Sector

Alibaba

Opinion Follows Trend. Sentiment is at an extreme low on Biotech and Chinese Tech.

Biotech And China Tech, Left For Dead. Time To Step In - XBI, BABA?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

How Are Biotech ETFs Reacting to These Q4 Earnings Releases?

AdvisorShares Pure US Cannabis ETF

They've taken a beating, but the industries they track are still growing.

3 Growth ETFs to Consider Buying During This Correction

The XBI Index has had an accumulated collapse in the last year of approximately 50%. It is a historic fall because it had never suffered such a collapse before.

XBI: The Worst Is Over

XBI: Market Runs From Risk In Times Of Uncertainty

Aurinia Pharmaceuticals

Bausch Health Companies Inc

Clovis Oncology

Myovant Sciences

Cassava Sciences Inc

Biotechs have been one of the worst performers for 2021 as the pandemic has wrought havoc in the sector. 2022 will likely entail a rotation out of high valuation sectors like technology into more depressed sectors like healthcare.

6 Top Biotech Ideas For 2022

ARK Innovation ETF

iShares MSCI EAFE Growth ETF

Amplify Online Retail ETF

iShares Russell Mid-Cap Growth ETF

Global X Lithium & Battery Tech ETF

Vanguard Small-Cap Growth

Vanguard Growth ETF

Vanguard FTSE Emerging Markets ETF

These growth ETFs offer exposure to higher-risk, higher-reward stocks while lessening the risk of a single stock torpedoing your returns.

9 Great Growth ETFs for 2022

2021 has been a real tough year for biotech investors, and the start of 2022 doesn't bring a sign of relief yet. Nonetheless, if history is of any guide, large trading volumes over the past month are an indication that better days might be waiting ahead.

Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead

Biogen

Direxion Daily S&P Biotech Bull 3X Shares

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

3 Biotech Stocks to Buy That Are Under Severe Pressure

ETF Battles: IBB Vs XBI

Despite economic uncertainty, big biopharma companies have tons of cash to spend on deals.

Will M&A Perk Up Biotech After a Miserable 2021?

APA Corporation

Asana

Coterra Energy

Disney

DocuSign

Devon Energy

EOG Resources

Ford Motor Company

Diamondback Energy

Kosmos Energy

monday.com

ServiceNow

VanEck Vectors Oil Services ETF

Plains GP Hlds

Paysafe

PayPal

Tellurian

Tesla

Twilio

Upstart Holdings

Vector Group

Xerox

SentinelOne

The Market is having crazy volatility, Does that mean retreat? No. What about inflation, What about soaring interest rates? Bad news? That isn't the message of the market.

I Spy With My Big Eagle Eye Some Stocks I May Want To Buy

Adagio Therapeutics

Editas Medicine

All three of these biotech stocks lost around half their value over the past few months.

3 Beaten-Down Biotech Stocks -- Are They Bargains Now?

Invesco S&P 500 Enhanced Value ETF

SPDR S&P 500 ETF Trust

Vanguard Financials ETF

Invesco S&P MidCap Value with Momentum ETF

SPDR S&P Retail ETF

With the easing of Omicron fears, Wall Street jumped to start a new week after a broad market sell-off in the past couple of weeks.

5 Top-Ranked ETFs to Buy At Bargain Prices

Adaptimmune Therapeutics

Affimed

Axsome Therapeutics

BridgeBio Pharma Inc

BioCryst Pharmaceuticals

Beam Therapeutics

Amicus Therapeutics

These eight stocks could rebound nicely over the next year and beyond.

8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022

Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms.

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

I had rated the SPDR S&P Biotech ETF as bullish in July 2020. The ETF's price spiked by 51% thereafter, and later, regressed to its mean. Historical data reveal that the ETF delivered solid price gains in the long run, but current market conditions suggest that it faces many headwinds in the near term.

SPDR S&P Biotech ETF: Of Headwinds And Tailwinds

You may feel strange that we hold the SPDR S&P Biotech ETF (XBI) for our retirement. It pays negligible dividends and the biotech sector is the opposite of the “safe” sectors that retirees go for.

XBI: 3 Reasons Why We Hold It In Our Retirement Portfolio

First Trust Financials AlphaDEX Fund

US Global Jets ETF

Global X Superdividend ETF

Vanguard Extended Market ETF

Wall Street has been wavering in recent sessions due to renewed virus fears, higher inflation and rising rate worries.

5 ETFs to Offer a Really Good Deal on Black Friday

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

Can Biotech ETFs Gain From Positive Booster Update?

iShares Core U.S. Aggregate Bond ETF

iShares Core MSCI EAFE ETF

iShares Russell 3000 ETF

Schwab U.S. Broad Market ETF

Vanguard Total Stock Market ETF

Building a core satellite ETF portfolio can give investors the best of two worlds.

ETFs All You Need For Portfolios

News for SPDR S&P Biotech ETF ETF (XBI)